Table 1 Immune responses measured in CoviCompare

From: A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project

Humoral immune responses

Spike serology, isotypes and subclasses

Neutralization and pseudoneutralization assays using SARS-CoV-2 (Wuhan strain and variants of concern)

Immunoprofiling/LIPS SARS-CoV-2 (S S1 S2 RBD)

Serology for other coronaviruses

T cell-mediated responses

FluoroSpot T cell assays

T cell-specific phenotyping (subgroup of FluoroSpot)

Memory B cell responses

Memory B cell ELISpot

B cell receptor repertoire

Innate immune responses

Transcriptomic analysis (3′ RNA sequencing)

Cytokines (Simoa) and anti-cytokines (ELISA)

Innate and B cell phenotyping

Mucosal immune response testing

IgA, IgM and IgG salivary anti-S and anti-RBD

IgA and IgG salivary anti-S ultrasensitive

ADCC/neutralization

  1. LIPS SARS-CoV-2 (S S1 S2 RBD), luciferase immunoprecipitation system (LIPS) assays using the SARS-CoV-2 ectodomain of the trimeric full spike protein (S) and subdomains S1 (amino acids 1–698), S2 (amino acids 686–1208) and the receptor-binding domain (RBD); Simoa, single-molecule array; ADCC, antibody-dependent cell toxicity.